Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer

CONCLUSIONS: Our study shows a low agreement between IR-CTCAE and PRO-CTCAE in the setting of proton therapy for prostate cancer. Compared to patient-reported outcomes, physicians underestimated the frequency and severity of urinary symptoms and diarrhea at the end of treatment. Continued use of PROs should be strongly encouraged.PMID:34604551 | PMC:PMC8463742 | DOI:10.1016/j.ctro.2021.09.003

Source: Clinical Prostate Cancer - October 4, 2021 Category: Cancer & Oncology Authors: Roman O Kowalchuk David Hillman Thomas B Daniels Carlos E Vargas Jean-Claude M Rwigema William W Wong Bradley J Stish Amylou C Dueck Richard Choo Source Type: research